Annual D&A
$1.19 M
-$34.00 K-2.78%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual depreciation & amortization is $1.19 million, with the most recent change of -$34.00 thousand (-2.78%) on December 31, 2023.
- During the last 3 years, INBX annual D&A has risen by +$172.00 thousand (+16.88%).
- INBX annual D&A is now -2.78% below its all-time high of $1.23 million, reached on December 31, 2022.
Performance
INBX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$760.00 K
+$284.00 K+59.66%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly depreciation & amortization is $760.00 thousand, with the most recent change of +$284.00 thousand (+59.66%) on September 30, 2024.
- Over the past year, INBX quarterly D&A has increased by +$284.00 thousand (+59.66%).
- INBX quarterly D&A is now -0.52% below its all-time high of $764.00 thousand, reached on March 31, 2019.
Performance
INBX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.89 M
+$456.00 K+31.71%
September 30, 2024
Summary
- As of February 8, 2025, INBX TTM depreciation & amortization is $1.89 million, with the most recent change of +$456.00 thousand (+31.71%) on September 30, 2024.
- Over the past year, INBX TTM D&A has increased by +$456.00 thousand (+31.71%).
- INBX TTM D&A is now at all-time high.
Performance
INBX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
INBX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.8% | +59.7% | +31.7% |
| 3 y3 years | +16.9% | +157.6% | +56.1% |
| 5 y5 years | +76.2% | +157.6% | +56.1% |
INBX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.8% | at low | at high | +158.5% | at high | +59.0% |
| 5 y | 5-year | -2.8% | +16.9% | at high | +220.7% | at high | +189.2% |
| alltime | all time | -2.8% | +198.5% | -0.5% | +311.1% | at high | +1154.3% |
Inhibrx Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $760.00 K(+59.7%) | $1.89 M(+31.7%) |
| Jun 2024 | - | $476.00 K(+32.2%) | $1.44 M(+14.5%) |
| Mar 2024 | - | $360.00 K(+20.8%) | $1.26 M(+5.5%) |
| Dec 2023 | $1.19 M(-2.8%) | $298.00 K(-2.0%) | $1.19 M(-0.3%) |
| Sep 2023 | - | $304.00 K(+3.4%) | $1.20 M(-0.4%) |
| Jun 2023 | - | $294.00 K(-0.3%) | $1.20 M(-1.1%) |
| Mar 2023 | - | $295.00 K(-2.3%) | $1.21 M(-1.0%) |
| Dec 2022 | $1.23 M(+2.5%) | $302.00 K(-2.3%) | $1.23 M(-0.4%) |
| Sep 2022 | - | $309.00 K(+0.7%) | $1.23 M(+0.8%) |
| Jun 2022 | - | $307.00 K(0.0%) | $1.22 M(+0.7%) |
| Mar 2022 | - | $307.00 K(0.0%) | $1.21 M(+1.3%) |
| Dec 2021 | $1.20 M | $307.00 K(+2.7%) | $1.20 M(+3.6%) |
| Sep 2021 | - | $299.00 K(+0.3%) | $1.15 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $298.00 K(+2.4%) | $1.10 M(+4.6%) |
| Mar 2021 | - | $291.00 K(+9.8%) | $1.05 M(+3.4%) |
| Dec 2020 | $1.02 M(-12.4%) | $265.00 K(+6.4%) | $1.02 M(+2.8%) |
| Sep 2020 | - | $249.00 K(0.0%) | $991.00 K(-21.6%) |
| Jun 2020 | - | $249.00 K(-2.7%) | $1.26 M(+93.0%) |
| Mar 2020 | - | $256.00 K(+8.0%) | $655.00 K(-43.7%) |
| Dec 2019 | $1.16 M(+72.0%) | $237.00 K(-54.6%) | $1.16 M(+25.6%) |
| Sep 2019 | - | $522.00 K(-245.0%) | $926.00 K(+129.2%) |
| Jun 2019 | - | -$360.00 K(-147.1%) | $404.00 K(-56.5%) |
| Mar 2019 | - | $764.00 K(+363.0%) | $929.00 K(+194.0%) |
| Dec 2018 | $676.00 K(+69.4%) | - | - |
| Jun 2018 | - | $165.00 K(+9.3%) | $316.00 K(+109.3%) |
| Mar 2018 | - | $151.00 K | $151.00 K |
| Dec 2017 | $399.00 K | - | - |
FAQ
- What is Inhibrx Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual D&A year-on-year change?
- What is Inhibrx Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly D&A year-on-year change?
- What is Inhibrx Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Inhibrx Biosciences?
- What is Inhibrx Biosciences TTM D&A year-on-year change?
What is Inhibrx Biosciences annual depreciation & amortization?
The current annual D&A of INBX is $1.19 M
What is the all time high annual D&A for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual depreciation & amortization is $1.23 M
What is Inhibrx Biosciences annual D&A year-on-year change?
Over the past year, INBX annual depreciation & amortization has changed by -$34.00 K (-2.78%)
What is Inhibrx Biosciences quarterly depreciation & amortization?
The current quarterly D&A of INBX is $760.00 K
What is the all time high quarterly D&A for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly depreciation & amortization is $764.00 K
What is Inhibrx Biosciences quarterly D&A year-on-year change?
Over the past year, INBX quarterly depreciation & amortization has changed by +$284.00 K (+59.66%)
What is Inhibrx Biosciences TTM depreciation & amortization?
The current TTM D&A of INBX is $1.89 M
What is the all time high TTM D&A for Inhibrx Biosciences?
Inhibrx Biosciences all-time high TTM depreciation & amortization is $1.89 M
What is Inhibrx Biosciences TTM D&A year-on-year change?
Over the past year, INBX TTM depreciation & amortization has changed by +$456.00 K (+31.71%)